IN2012DN03954A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN03954A IN2012DN03954A IN3954DEN2012A IN2012DN03954A IN 2012DN03954 A IN2012DN03954 A IN 2012DN03954A IN 3954DEN2012 A IN3954DEN2012 A IN 3954DEN2012A IN 2012DN03954 A IN2012DN03954 A IN 2012DN03954A
- Authority
- IN
- India
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28087909P | 2009-11-10 | 2009-11-10 | |
PCT/US2010/002950 WO2011059490A1 (en) | 2009-11-10 | 2010-11-09 | Heart aging biomarkers and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN03954A true IN2012DN03954A (es) | 2015-08-07 |
Family
ID=43991901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3954DEN2012 IN2012DN03954A (es) | 2009-11-10 | 2012-05-04 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20120220488A1 (es) |
EP (1) | EP2499260B1 (es) |
JP (1) | JP5901530B2 (es) |
CN (1) | CN102695807B (es) |
AU (1) | AU2010318703B2 (es) |
BR (1) | BR112012011133A2 (es) |
CA (1) | CA2779606A1 (es) |
ES (1) | ES2641491T3 (es) |
IN (1) | IN2012DN03954A (es) |
MX (1) | MX345333B (es) |
RU (1) | RU2562174C2 (es) |
WO (1) | WO2011059490A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3062108B1 (en) * | 2011-02-24 | 2019-06-19 | Hill's Pet Nutrition, Inc. | Methods for diagnosing kidney disorders in a feline |
CN105868532B (zh) * | 2016-03-22 | 2019-03-05 | 曾金生 | 一种智能评估心脏衰老程度的方法及系统 |
EP3529379B1 (en) | 2016-10-24 | 2022-05-18 | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO | System and method for implementing meal selection based on vitals, genotype, and phenotype |
CN110157788A (zh) * | 2019-04-04 | 2019-08-23 | 东莞市第八人民医院(东莞市儿童医院) | 一种用于定量检测SENP2 mRNA水平的引物、探针和试剂盒 |
CN111366736A (zh) * | 2020-03-31 | 2020-07-03 | 中国科学院昆明动物研究所 | 指征健康衰老关键通路的血清蛋白质标志物及应用 |
US11139064B1 (en) * | 2020-12-29 | 2021-10-05 | Kpn Innovations, Llc. | Systems and methods for generating a body degradation reduction program |
US12087428B2 (en) * | 2020-12-29 | 2024-09-10 | Kpn Innovations Llc | Systems and methods for generating a body degradation reduction program |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2112543C1 (ru) * | 1996-09-26 | 1998-06-10 | Александр Григорьевич Хоменко | Иммуномодулирующее лекарственное средство |
CA2381777C (en) * | 1999-08-12 | 2011-10-04 | Wisconsin Alumni Research Foundation | Identification of genetic markers of biological age and metabolism |
US6406853B1 (en) | 1999-12-23 | 2002-06-18 | The Regents Of The University Of California | Interventions to mimic the effects of calorie restriction |
DE60039190D1 (de) | 1999-12-23 | 2008-07-24 | Univ California | Massnahmen welche die effekte einer kalorischen beschränkung nachahmen |
MXPA05003705A (es) * | 2002-10-09 | 2005-08-16 | Central Iowa Health System | Vacunacion antitumoral usando celulas de tumor alogeneico que expresan alfa (1,3)-galactosil transferasa. |
US20040180003A1 (en) | 2003-03-12 | 2004-09-16 | Spindler Stephen R. | Methods of screening for caloric restriction mimetics and reproducing effects of caloric restriction |
US20040191775A1 (en) | 2003-03-12 | 2004-09-30 | Spindler Stephen R. | Methods of analyzing genes affected by caloric restriction or caloric restriction mimetics |
US20050013776A1 (en) | 2003-07-16 | 2005-01-20 | Spindler Stephen R. | Methods of evaluating the dynamics of caloric restriction and identifying caloric restriction mimetics |
EP2289504A3 (en) * | 2003-07-01 | 2012-05-23 | President and Fellows of Harvard College | SIRT1 modulators for manipulating cell/organism lifespan/stress response |
CA2611743C (en) * | 2005-06-15 | 2019-12-31 | Callida Genomics, Inc. | Nucleic acid analysis by forming and tracking aliquoted fragments of a target polynucleotide |
US20070196850A1 (en) * | 2006-01-27 | 2007-08-23 | University Of Washington | Identification of aging genes through large-scale analysis |
ES2543808T3 (es) | 2006-02-01 | 2015-08-24 | Nestec S.A. | Sistema nutricional y métodos para aumentar la longevidad |
JP2010508846A (ja) * | 2006-11-09 | 2010-03-25 | ザ ジェイ.ディヴィッド グラッドストン インスティテューツ | 心筋形成を誘発するための方法 |
EP2222837A2 (en) * | 2007-02-09 | 2010-09-01 | The General Hospital Corporation | Methods for the induction of a cell to enter the islet 1+ lineage and a method for the expansion thereof |
WO2009091550A2 (en) * | 2008-01-14 | 2009-07-23 | Bayer Healthcare Llc | Sulfone substituted 2,3-dihydroimidazo [1,2-c] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis |
-
2010
- 2010-11-09 JP JP2012537864A patent/JP5901530B2/ja active Active
- 2010-11-09 US US13/505,912 patent/US20120220488A1/en not_active Abandoned
- 2010-11-09 EP EP10830319.9A patent/EP2499260B1/en active Active
- 2010-11-09 CA CA2779606A patent/CA2779606A1/en not_active Abandoned
- 2010-11-09 AU AU2010318703A patent/AU2010318703B2/en not_active Ceased
- 2010-11-09 RU RU2012123990/10A patent/RU2562174C2/ru not_active IP Right Cessation
- 2010-11-09 CN CN201080060948.6A patent/CN102695807B/zh not_active Expired - Fee Related
- 2010-11-09 BR BR112012011133A patent/BR112012011133A2/pt not_active IP Right Cessation
- 2010-11-09 MX MX2012005355A patent/MX345333B/es active IP Right Grant
- 2010-11-09 WO PCT/US2010/002950 patent/WO2011059490A1/en active Application Filing
- 2010-11-09 ES ES10830319.9T patent/ES2641491T3/es active Active
-
2012
- 2012-05-04 IN IN3954DEN2012 patent/IN2012DN03954A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2779606A1 (en) | 2011-05-19 |
ES2641491T3 (es) | 2017-11-10 |
BR112012011133A2 (pt) | 2016-07-05 |
CN102695807A (zh) | 2012-09-26 |
EP2499260A1 (en) | 2012-09-19 |
EP2499260B1 (en) | 2017-08-23 |
RU2012123990A (ru) | 2013-12-20 |
RU2562174C2 (ru) | 2015-09-10 |
WO2011059490A1 (en) | 2011-05-19 |
CN102695807B (zh) | 2016-02-24 |
AU2010318703A1 (en) | 2012-05-31 |
JP5901530B2 (ja) | 2016-04-13 |
US20120220488A1 (en) | 2012-08-30 |
EP2499260A4 (en) | 2013-07-17 |
MX2012005355A (es) | 2012-05-29 |
AU2010318703B2 (en) | 2016-08-25 |
MX345333B (es) | 2017-01-25 |
JP2013509877A (ja) | 2013-03-21 |